# Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease

> **NCT00316992** · PHASE4 · COMPLETED · sponsor: **Takeda** · enrollment: 25 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Ramelteon and Placebo

## Key facts

- **NCT ID:** NCT00316992
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2010-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00316992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00316992, "Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00316992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*